The Association Between Cholecystectomy and the Risk for Fracture: A Nationwide Population-Based Cohort Study in Korea

Abstract

ObjectivesTo evaluate the risk of fracture in individuals with a history of cholecystectomy in Korean population.MethodsIndividuals (n = 143,667) aged ≥ 40 y who underwent cholecystectomy between 2010 and 2015 and the controls (n = 255,522), matched by age and sex, were identified from the database of the Korean National Health Insurance Services. The adjusted hazard ratio (aHR) and 95% confidence interval (CI) of fracture were estimated following cholecystectomy, and a Cox regression analysis was performed.ResultsThe incidence rates of all fractures, vertebral, and hip fractures were 14.689, 6.483 and 1.228 cases per 1000 person-years respectively in the cholecystectomy group, whereas they were 13.862, 5.976, and 1.019 cases per 1000 person-years respectively in the control group. After adjustment for age, sex, income, place of residence, diabetes mellitus, hypertension, dyslipidemia, smoking, alcohol drinking, exercise, and body mass index, patients who underwent cholecystectomy showed an increased risk of all fractures, vertebral fractures, and hip fractures (aHR [95% CI]: 1.095 [1.059-1.132], 1.134 [1.078-1.193], and 1.283 [1.139-1.444] for all fractures, vertebral fractures, and hip fractures, respectively). The risk of vertebral fractures following cholecystectomy was more prominent in the young age group (40 to 49 y) than in the old age group (≥ 65 y) (1.366 [1.082-1.724] vs. 1.132 [1.063-1.206], respectively). However, the incidence of hip fractures following cholecystectomy was not affected by age.ConclusionIndividuals who underwent cholecystectomy have an increased risk of fracture. In the younger population, the risk of vertebral fractures may be further increased following cholecystectomy.

Genetic Associations of Lipid-Lowering Drugs and Parkinson’s Disease: A Mendelian Randomization Study

“…Other non-MR studies have also reported varied conclusions [21][22][23][24][25] . Interpreting the above studies alongside our study results, which showed that only HMGCR inhibition, not NPC1L inhibition and PCSK9 inhibition, was correlated with a reduced risk of PD.…”

“…A handful of literature has explored the association between lipid-lowering drugs or serum lipid levels and PD, yet the results have been inconsistent [19][20][21][22][23][24][25][26] . In a MR study using a Danish dataset, no association was detected between LDL and the risk of PD, whereas a separate MR study conducted by a Swedish team suggested a causal inverse association of LDL with PD risk 19,27 .…”

Late hepatitis C virus diagnosis among patients with newly diagnosed hepatocellular carcinoma: a case–control study

“…Furthermore, DM may lead to more severe liver inflammation and fibrosis progression [ 40 ]. DM might be mediated by binding of insulin-like growth factor-1 (IGF-1) to the IGF-1 receptor and activate mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) signaling pathways leading to increased cell proliferation and decreased apoptosis [ 41 ]. Insulin resistance (IR), which has a negative impact on antiviral therapy responses [ 42 ] and liver-related outcomes [ 43 ], plays a crucial role in fibrosis progression.…”

Characteristics of Osteoporosis Patients with Gallstone Formation in Cholelithiasis Patients with Malignant Neuroleptic Syndrome

“…Cholecystectomy is a popular surgical operation, and patients who have had cholecystectomy are frequently encountered in clinical practice. Gallstones are the most common reason for cholecystectomy, followed by cholecystitis (Lee et al, 2021).…”